Uncategorized Archives - Page 153 of 168

1 minute read

Uncategorized

Infosys Collaborates with GE Digital to Deliver Energy Transition Solutions

February 7, 6:23 AM

Together, GE Digital and Infosys will follow a joint go-to-market approach to deliver value added solutions for grid related products and services, for their new and existing clients. Infosys and GE Digital will

1 minute read

Uncategorized

Sensei Biotherapeutics Signs Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to Expand Development Plan for SNS-101, a Conditionally Active VISTA-blocking Antibody

By Benzinga Newsdesk

February 6, 8:33 AM

Under the terms of the CRADA, Sensei will collaborate with the NCI Center for Immuno-Oncology Co-Directors, Jeffrey Schlom, Ph.D., and James Gulley, M.D., Ph.D., and conduct preclinical studies to assess the mechanism of

SNSE

1 minute read

Uncategorized

Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT

By Benzinga Newsdesk

February 6, 8:07 AM

New next-generation sequencing kit maximizes throughput and decreases the cost for single cell experiments. Company announces increased quality and throughput specifications of the G4 Sequencing Platform

OMIC

1 minute read

Uncategorized

Linde to Invest $1.8 Billion to Supply Clean Hydrogen to OCI’s World-Scale Blue Ammonia Project in the U.S. Gulf Coast

By Benzinga Newsdesk

February 6, 7:22 AM

Linde will build, own and operate an on-site complex which will include autothermal reforming with carbon capture, plus a large air separation plant. The new complex will be integrated into Linde's extensive

LIN

1 minute read

Uncategorized

Alvotech Enters Into Commercialization Agreement With Advanz Pharma for Proposed Biosimilar to Xolair

By Benzinga Newsdesk

February 6, 5:27 AM

Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area, UK, Switzerland, Canada, Australia, and New Zealand

ALVO

1 minute read

Uncategorized

Calliditas Receives Conditional Marketing Authorization from UK MHRA for Kinpeygo in IgA nephropathy

By Benzinga Newsdesk

February 2, 4:46 AM

Kinpeygo is the first and only approved treatment for IgAN, a rare, progressive autoimmune disease of the kidney with a high unmet need, with more than 50% of patients potentially progressing to end-stage renal

CALT

1 minute read

Uncategorized

Li Auto January 2023 Delivery Increases 23.4%

By Benzinga Newsdesk

February 1, 4:43 AM

The Company delivered 15,141 vehicles in January 2023. The cumulative deliveries of Li Auto vehicles reached 272,475 as of the end of January.

1 minute read

Uncategorized

JD Shop Now Sales Increased 90% During Chinese Spring Festival

By Benzinga Newsdesk

January 31, 5:24 AM

Data from JD Shop Now shows that during the Chinese New Year period, sales of mobile phones increased by more than 70% compared to the previous year, cosmetics and perfume sales increased by more

DADA

1 minute read

Uncategorized

Barrick Gold Pays First $3M To Balochistan Provincial Government As Part Of The New Reko Diq Partnership.

By Benzinga Newsdesk

January 31, 4:54 AM

The new Reko Diq agreement ensures that benefits from the project start accruing to the people of Balochistan well before the mine goes into production through advance royalties and social development funds.

GOLD

1 minute read

Uncategorized

Aptar Pharma, Part Of AptarGroup Inc Announces The Launch Of APF Futurity, Its First Metal-free, Multidose Nasal Spray Pump

By Benzinga Newsdesk

January 30, 9:53 AM

The spray pump is developed to deliver nasal saline and other comparable over-the-counter (OTC) formulations.

ATR